Avity Investment Management Inc. Decreases Stake in Mettler-Toledo International, Inc. $MTD

Avity Investment Management Inc. reduced its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 4.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 355 shares of the medical instruments supplier’s stock after selling 16 shares during the period. Avity Investment Management Inc.’s holdings in Mettler-Toledo International were worth $417,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of MTD. Cetera Investment Advisers raised its stake in Mettler-Toledo International by 8.7% during the fourth quarter. Cetera Investment Advisers now owns 1,075 shares of the medical instruments supplier’s stock worth $1,315,000 after purchasing an additional 86 shares during the period. ProShare Advisors LLC raised its stake in Mettler-Toledo International by 7.5% during the fourth quarter. ProShare Advisors LLC now owns 4,265 shares of the medical instruments supplier’s stock worth $5,219,000 after purchasing an additional 299 shares during the period. Rafferty Asset Management LLC raised its stake in Mettler-Toledo International by 11.4% during the fourth quarter. Rafferty Asset Management LLC now owns 2,398 shares of the medical instruments supplier’s stock worth $2,934,000 after purchasing an additional 246 shares during the period. Royal Bank of Canada raised its stake in Mettler-Toledo International by 7.3% during the fourth quarter. Royal Bank of Canada now owns 45,756 shares of the medical instruments supplier’s stock worth $55,990,000 after purchasing an additional 3,105 shares during the period. Finally, Sherbrooke Park Advisers LLC purchased a new position in Mettler-Toledo International during the fourth quarter worth about $245,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,258.06 on Monday. The stock has a market capitalization of $25.92 billion, a P/E ratio of 31.86, a price-to-earnings-growth ratio of 3.78 and a beta of 1.37. The company has a 50 day moving average price of $1,258.94 and a 200 day moving average price of $1,184.82. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares of the company’s stock, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 0.77% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MTD shares. Robert W. Baird lifted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Barclays initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target on the stock. Bank of America boosted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a “neutral” rating in a research note on Thursday, June 26th. UBS Group raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and reduced their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Evercore ISI reduced their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Moderate Buy” and an average target price of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.